Abstract
Male breast cancers (MBCs) are relatively uncommon malignancy with less than 1% incidence. MBC presents at a later age with a more advanced presentation as compared to the female breast cancer. Due to the paucity of the number of cases and trials regarding the MBC, female breast cancer treatment protocols are applied. Mastectomy and hormonal therapy remains the mainstay of treatment. Moreover, the data about prognosis of MBC remains limited.
Cite
CITATION STYLE
Kale, S., Rammohan, R., Vas, V., & Elsayad, C. (2020). Male Breast Cancer: Reevaluate Our Opinion. Case Reports in Oncological Medicine, 2020, 1–3. https://doi.org/10.1155/2020/6245415
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.